Viewing nowPregabalin Capsule 50 mg (Pregabalin)
Pregabalin 50mg
Hard capsule · Prescription medication
Eden Pharma Co., Ltd.

MFDS item code 202001647 · Approved 2020.03.10 · Insurance code 628901630
Treatment of neuropathic pain; adjunctive treatment of partial-onset seizures in epilepsy; treatment of fibromyalgia
This medication is used to treat peripheral and central neuropathic pain in adults. It is also utilized as an adjunctive treatment for patients with epilepsy who have partial seizures, effective regardless of the presence of secondary generalized symptoms. Additionally, it helps in the treatment of fibromyalgia. Due to these diverse effects, it is used to improve various neurological symptoms.
This medicine is administered orally as pregabalin, with the total daily dose divided into 2 doses, regardless of food. Since this medicine is primarily excreted by the kidneys, the dose should be adjusted in patients with impaired renal function. (See section ‘5. Patients with renal impairment’) 1. Neuropathic pain 1) Peripheral neuropathic pain Adults: This medicine may be administered at an initial dose of 150 mg/day. Based on the response and tolerability of each patient, the dose may be increased to 300 mg/day after 3 to 7 days. If necessary, it may subsequently be increased at 7-day intervals up to a maximum of 600 mg/day. 2) Central neuropathic pain Adults: This medicine may be administered at an initial dose of 150 mg/day. Based on the response and tolerability of each patient, the dose may be increased to 300 mg/day after 1 week. After an additional 1 week, it may be increased to the target daily dose of 600 mg. If the target daily dose is not tolerated, dose reduction may be considered. (See section ‘4. Discontinuation of treatment’) 2. Epilepsy Adults: This medicine may be administered at an initial dose of 150 mg/day. Based on the response and tolerability of each patient, the dose may be increased to 300 mg/day after 1 week. If necessary, it may subsequently be increased at 7-day intervals up to a maximum of 600 mg/day. 3. Fibromyalgia The recommended dose of this medicine for fibromyalgia is 300 mg-450 mg/day. The starting dose is 75 mg twice daily (150 mg/day), and based on efficacy and tolerability, it may be increased within 1 week to 150 mg twice daily (300 mg/day). For patients who do not experience sufficient benefit at a dose of 300 mg/day, it may be increased within 1 week to 225 mg twice daily (450 mg/day). Clinical studies have also been conducted at a dose of 600 mg/day, but there is no evidence of additional benefit or adequate tolerability at this dose. In view of dose-dependent adverse reactions, doses exceeding 450 mg/day are not recommended. 4. Discontinuation of treatment Based on current clinical experience, if treatment with this medicine is discontinued, it should be tapered gradually over at least 1 week. 5. Patients with renal impairment After entering the systemic circulation, this medicine is primarily excreted by the kidneys in unchanged form. Since the clearance of this medicine is directly affected by creatinine clearance, dose reductions in patients with impaired renal function should be individualized based on creatinine clearance. Creatinine clearance [Table 1] is determined using the formula below. Creatinine clearance (mL/min)* = [140 – age (years)] x body weight (kg) 72 x serum creatinine concentration (serum creatinine, mg/dL) * For women, multiply the result obtained from the above formula by 0.85. This medicine is effectively removed from plasma by hemodialysis (approximately 50% within 4 hours). In patients undergoing hemodialysis, the daily dose of pregabalin should be adjusted based on renal function. In addition to the daily dose based on renal function, a supplementary dose should be administered immediately after each 4-hour hemodialysis session. [Table 1] Pregabalin dosage based on renal function Creatinine clearance (CLcr), (mL/min) Total daily dose of pregabalina Administration method Starting dose (mg/day) Maximum dose (mg/day) ≥60 150 600 BID or TID ≥30-<60 75 300 BID or TID ≥15-<30 25-50 150 QD or BID <15 25 75 QD Supplementary dose after hemodialysis 25 100 Single dose b TID = Total daily dose administered in 3 divided doses BID = Total daily dose administered in 2 divided doses QD = Administered once daily a: The total daily dose (mg/day) should be administered in divided doses as specified under the administration method. b: The supplementary dose refers to a dose administered as a single additional dose. 6. Patients with hepatic impairment No dose adjustment is necessary in patients with hepatic impairment. 8. Elderly patients (65 years of age or older) Dose reduction may be necessary in elderly patients with impaired renal function.
Children under 12 years of age: Administration is not recommended because there are insufficient data on safety and efficacy. Adolescent patients aged 12-17 years: Administration is not recommended because there are insufficient data on safety and efficacy.
This medication may increase the risk of suicidal thoughts or behaviors, so if mood changes or depressive symptoms arise during treatment, consult a doctor immediately. Individuals allergic to any components of this medication or those with certain genetic disorders should not take it. Diabetic patients should be cautious as weight gain may require adjustments to blood sugar control medications. If allergic reactions such as swelling of the face or neck occur, discontinue this medication immediately and inform healthcare personnel. Elderly individuals are at a higher risk for falls due to dizziness or drowsiness, so extra caution is needed during the early stage of treatment. This medication can cause temporary blurred vision or changes in vision, and if these symptoms arise, consult a doctor. Suddenly stopping this medication may lead to withdrawal symptoms such as insomnia, headache, nausea, and anxiety, so it should be gradually reduced according to a doctor's advice. Patients with a history of substance abuse should be monitored closely while taking this medication due to the risk of misuse. Patients with reduced kidney function may need to adjust the dosage of this medication; taking it without dosage adjustment can increase the risk of side effects. Patients with heart disease need to be cautious while taking this medication, especially those with congestive heart failure must be administered carefully. Caution is advised when taking this medication with opioid analgesics as it can amplify central nervous system depressant effects, which may increase the risk of respiratory distress. During early pregnancy, this may affect the fetus, therefore women who are pregnant or planning to become pregnant should consult a doctor before use. Women who are breastfeeding should consult healthcare professionals since this medication can be transferred into breast milk. Activities requiring concentration, such as driving or operating machinery, should be avoided until dizziness or drowsiness subsides post-consumption of this medication. In case of overdose, symptoms such as confusion, drowsiness, and depression may occur, necessitating immediate medical attention.
Not everyone experiences these, and they can vary from person to person.
This medication should be kept in a well-sealed container to prevent exposure to air and moisture, stored at room temperature between 15 and 30 degrees Celsius. This way of storage helps to maintain the efficacy of the medication and ensure its safe usage.
Hard capsule in dark blue on the upper side and white on the lower side, containing white powder.
30 capsules/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowPregabalin 50mg
Hard capsule · Prescription medication
Eden Pharma Co., Ltd.

Pregabalin 75mg
Hard capsule · Prescription medication
Viatris Korea Co., Ltd.

Pregabalin 150mg
Hard capsule · Prescription medication
Viatris Korea Co., Ltd.

Pregabalin 300mg
Hard capsule · Prescription medication
Viatris Korea Co., Ltd.

Pregabalin 150mg
Hard capsule · Prescription medication
Samjin Pharmaceutical Co., Ltd.

Pregabalin 75mg
Hard capsule · Prescription medication
Samjin Pharmaceutical Co., Ltd.

Pregabalin 75mg
Hard capsule · Prescription medication
Hanmi Pharm. Co., Ltd.

Pregabalin 150mg
Hard capsule · Prescription medication
Hanmi Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.